Your browser doesn't support javascript.
loading
Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
Gao, Xiao-Ning; Su, Yong-Feng; Li, Meng-Yue; Jing, Yu; Wang, Jun; Xu, Lei; Zhang, Lin-Lin; Wang, An; Wang, Yi-Zhi; Zheng, Xuan; Li, Yan-Fen; Liu, Dai-Hong.
Afiliación
  • Gao XN; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China. gaoxn@263.net.
  • Su YF; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.
  • Li MY; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.
  • Jing Y; Graduate School, Chinese PLA General Hospital, Beijing, 100853, China.
  • Wang J; Department of Hematology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Xu L; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.
  • Zhang LL; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.
  • Wang A; Department of Hematology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Wang YZ; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.
  • Zheng X; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.
  • Li YF; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.
  • Liu DH; Department of Hematology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Cancer Immunol Immunother ; 72(8): 2769-2782, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37166484
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: China